SHAREHOLDERS' EQUITY - Narrative (Details)			3 Months Ended		76 Months Ended
	Jul. 18, 2021	Feb. 04, 2020 USD ($) sales_agent	Jun. 30, 2025 USD ($) $ / shares shares	Jun. 30, 2024 USD ($) $ / shares shares	Jun. 30, 2025 USD ($) $ / shares shares	May 21, 2024 USD ($)	May 20, 2024 USD ($)	Aug. 02, 2022 USD ($)	Aug. 01, 2022 USD ($)	Aug. 31, 2021 USD ($)	Jul. 28, 2021 USD ($)	May 26, 2021 USD ($)	Mar. 04, 2019 USD ($)
Subsidiary or Equity Method Investee [Line Items]
Repurchase authorized amount										$ 20,000,000	$ 20,000,000
Restricted Stock | 2010 Plan
Subsidiary or Equity Method Investee [Line Items]
Right to grant period	10 years
Equity ATM Program
Subsidiary or Equity Method Investee [Line Items]
Maximum consideration threshold		$ 100,000,000.0				$ 1,000,000,000	$ 650,000,000	$ 650,000,000.0	$ 250,000,000.0			$ 250,000,000.0	$ 50,000,000.0
Number of additional sales agents | sales_agent		2
Gross sales commission percentage		2.00%										1.50%
Number of shares sold (in shares) | shares			2,034,917	1,498,981	35,076,094
Weighted average price per share (in usd per share) | $ / shares			$ 20.50	$ 25.60	$ 21.43
Gross proceeds received			$ 41,725,000	$ 38,367,000	$ 751,700,000
Net proceeds received			41,197,000	$ 37,792,000	740,200,000
Available under the equity ATM program			$ 248,300,000		$ 248,300,000